Suppr超能文献

转移性视网膜母细胞瘤的临床特征、治疗及预后

Metastatic retinoblastoma clinical features, treatment, and prognosis.

作者信息

Gündüz Kaan, Müftüoglu Orkun, Günalp Ilhan, Unal Emel, Taçyildiz Nurdan

机构信息

Department of Ophthalmology, Ankara University Faculty of Medicine, Ankara, Turkey.

出版信息

Ophthalmology. 2006 Sep;113(9):1558-66. doi: 10.1016/j.ophtha.2006.03.039. Epub 2006 Jul 7.

Abstract

PURPOSE

To evaluate the clinical features, treatment, and prognosis in patients with metastatic retinoblastoma.

DESIGN

Retrospective interventional case series.

PARTICIPANTS

Eighteen consecutive patients with metastatic retinoblastoma who were diagnosed and managed at the Oncology Service of Ankara University, Turkey, between January 1999 and January 2005.

METHODS

All patients underwent magnetic resonance imaging (MRI) of the orbit and brain, lumbar puncture, bone marrow aspiration, and bone scintigraphy for metastatic evaluation. Histopathologic confirmation of retinoblastoma via enucleation, exenteration, or orbital biopsy was obtained in each patient. The status of extraocular spread (optic nerve, extrascleral extension, or both) was assessed based on histopathologic or MRI results. Systemic treatment for metastatic retinoblastoma consisted of chemotherapy and radiotherapy (craniospinal, orbital, or both), if necessary.

MAIN OUTCOME MEASURES

Status of extraocular spread, site of metastasis, and survival from metastatic retinoblastoma.

RESULTS

At presentation, the mean patient age was 45 months (range, 13-86). Ten patients had unilateral retinoblastoma, 7 had bilateral retinoblastoma, and 1 had trilateral retinoblastoma. All patients with metastatic retinoblastoma had histopathologic or MRI evidence of unilateral extraocular disease characterized by optic nerve involvement, extrascleral extension, or both. Nine of 18 patients experienced central nervous system (CNS) involvement, 5 patients had distant and CNS metastasis, and 4 patients had distant metastasis only. Fourteen patients underwent craniospinal irradiation and 12 had orbital irradiation. At a mean follow-up of 24 months (range, 4-62), all patients with CNS and concurrent distant and CNS metastasis were deceased. Four patients who had distant metastasis only were alive at a follow-up ranging from 9 to 62 months.

CONCLUSIONS

The prognosis for metastatic retinoblastoma is dismal and the presence of CNS involvement may portend an even worse outcome.

摘要

目的

评估转移性视网膜母细胞瘤患者的临床特征、治疗方法及预后情况。

设计

回顾性干预病例系列研究。

研究对象

1999年1月至2005年1月期间在土耳其安卡拉大学肿瘤科室确诊并接受治疗的18例连续性转移性视网膜母细胞瘤患者。

方法

所有患者均接受眼眶和脑部的磁共振成像(MRI)、腰椎穿刺、骨髓穿刺及骨闪烁显像以评估转移情况。通过眼球摘除术、眶内容剜除术或眼眶活检对每位患者的视网膜母细胞瘤进行组织病理学确诊。根据组织病理学或MRI结果评估眼外扩散(视神经、巩膜外扩展或两者皆有)情况。转移性视网膜母细胞瘤的全身治疗包括化疗和放疗(全脑脊髓、眼眶或两者皆有),必要时采用。

主要观察指标

眼外扩散情况、转移部位及转移性视网膜母细胞瘤患者的生存率。

结果

就诊时,患者的平均年龄为45个月(范围13 - 86个月)。10例患者为单侧视网膜母细胞瘤,7例为双侧视网膜母细胞瘤,1例为三边性视网膜母细胞瘤。所有转移性视网膜母细胞瘤患者均有组织病理学或MRI证据表明存在单侧眼外疾病,其特征为视神经受累、巩膜外扩展或两者皆有。18例患者中有9例出现中枢神经系统(CNS)受累,5例有远处及CNS转移,4例仅有远处转移。14例患者接受了全脑脊髓照射,12例接受了眼眶照射。平均随访24个月(范围4 - 62个月),所有CNS受累及同时伴有远处和CNS转移的患者均死亡。4例仅有远处转移的患者在随访9至62个月时仍存活。

结论

转移性视网膜母细胞瘤的预后不佳,中枢神经系统受累可能预示着更差的结局。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验